Harmful body care products - An insight into a possible detoxification pathway in humans by AKR1B1 and AKR1B10

被引：0
|
作者：
Appel, D. [1 ]
Hintzpeter, J. [1 ]
Martin, H. J. [1 ]
Maser, E. [1 ]
机构：
[1] Univ Med Sch Schleswig Holstein Campus Kiel, Inst Toxicol & Pharmacol Nat Scientists, Kiel, Germany
来源：
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY | 2018年 / 391卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
P90
引用
收藏
页码：S45 / S45
页数：1
相关论文
共 50 条
  • [41] Induced fit binding of aldose reductase inhibitors to AKR1B10
    Shah, Anup
    Shinde, Ranajit
    Kare, Pavan
    Hymavathi, V.
    Chavan, Swapnil
    Sobhia, M. Elizabeth
    MEDICINAL CHEMISTRY RESEARCH, 2012, 21 (07) : 1245 - 1252
  • [42] Prognostic significance of AKR1B10 in patients with resected lung adenocarcinoma
    Hung, Jung-Jyh
    Yeh, Yi-Chen
    Hsu, Wen-Hu
    THORACIC CANCER, 2018, 9 (11) : 1492 - 1499
  • [43] The AKR1B1 inhibitor epalrestat suppresses the progression of cervical cancer
    Jie Ji
    Min-Xue Xu
    Tian-Yang Qian
    Sheng-Ze Zhu
    Feng Jiang
    Zhao-Xiu Liu
    Wei-Song Xu
    Juan Zhou
    Ming-Bing Xiao
    Molecular Biology Reports, 2020, 47 : 6091 - 6103
  • [44] The AKR1B1 inhibitor epalrestat suppresses the progression of cervical cancer
    Ji, Jie
    Xu, Min-Xue
    Qian, Tian-Yang
    Zhu, Sheng-Ze
    Jiang, Feng
    Liu, Zhao-Xiu
    Xu, Wei-Song
    Zhou, Juan
    Xiao, Ming-Bing
    MOLECULAR BIOLOGY REPORTS, 2020, 47 (08) : 6091 - 6103
  • [45] INDUCED FIT BINDING OF ALDOSE REDUCTASE INHIBITOR ZOPOLRESTAT TO AKR1B10
    Shinde, Ranajit
    Shah, Anup
    Kare, Pavan
    Chavan, Swapnil
    Hymavathi, V.
    Sobhia, M. Elizabeth
    MEDICINAL CHEMISTRY RESEARCH, 2010, 19 : S54 - S54
  • [46] Synthesis and biological evaluation of steroidal derivatives as selective inhibitors of AKR1B10
    Zhang, Wei
    Wang, Ling
    Zhang, Liping
    Chen, Wenli
    Chen, Xinying
    Xie, Minyu
    Yan, Guangmei
    Hu, Xiaopeng
    Xu, Jun
    Zhang, Jingxia
    STEROIDS, 2014, 86 : 39 - 44
  • [47] AKR1B10 and CBR1 inhibitors to improve the efficacy of anthracyclines in cancer treatment
    Sardelli, G.
    Piazza, L.
    Maccari, R.
    Ottana, R.
    Mosca, R.
    Felice, F.
    Signore, G.
    Balestri, F.
    Cappiello, M.
    Del Corso, A.
    Moschini, R.
    FEBS OPEN BIO, 2024, 14 : 300 - 300
  • [48] AKR1B10 expression predicts response of gastric cancer to neoadjuvant chemotherapy
    Ahmed, Syed Minhaj Uddin
    Jiang, Zi Nong
    Zheng, Zhao Hong
    Li, Yulong
    Wang, Xiu Jun
    Tang, Xiuwen
    ONCOLOGY LETTERS, 2019, 17 (01) : 773 - 780
  • [49] Clinical value of AKR1B10 in hepatocellular carcinoma: A systematic review and metaanalysis
    Wang, Zixiang
    Pei, Yinxuan
    Li, Weiwei
    Zhang, Jingxiao
    Liu, Jinlong
    PLOS ONE, 2022, 17 (12):
  • [50] AKR1B10 expression in benign prostatic hyperplasia and its related mechanism
    Xu, Wenjing
    Gao, Ya
    Zhang, Jiaqi
    Zhang, Rong
    Chen, Qihua
    ONCOLOGY LETTERS, 2021, 22 (03)
12345